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Introduction
We have recently shown that the early stages of two forms of experimental pancreatitis (diet-induced and secretagogue-induced) share the common attribute of colocalization of digestive enzyme zymogens with lysosomal hydrolases inside large cytoplasmic vacuoles. This conclusion was based on the results of morphological studies using immunolocalization techniques which demonstrated the presence ofdigestive zymogens as well as lysosomal hydrolases within the same organelle (1) (2) (3) and on the results of biochemical studies which used subcellu-lar fractionation techniques to demonstrate redistribution of cathepsin B and other lysosomal enzymes from the lysosomeenriched to the zymogen granule-enriched fraction (4, 5) . Subcellular redistribution and colocalization of cathepsin B with digestive zymogens was also noted to follow pancreatic duct obstruction (6) . Because cathepsin B can activate trypsinogen (7) and trypsin can activate the other digestive zymogens, the colocalization of digestive enzyme zymogens with lysosomal hydrolases could lead to intracellular digestive enzyme activation and be an important triggering event in the development of acute pancreatitis (8) .
The secretagogue-induced model ofexperimental pancreatitis involves infusing rats with a dose of the cholecystokinin analogue caerulein in excess of that required to cause a maximal rate of digestive enzyme secretion from the pancreas (9, 10) . Within 3-4 h ofbeginning that infusion, hyperamylasemia and massive interstitial pancreatic edema occur (10) , and the redistribution of lysosomal enzymes to the zymogen granuleenriched fraction can be demonstrated (4) . In the current communication, we report the results ofstudies which demonstrate that the redistribution phenomenon can be reproduced in a completely in vitro system. They indicate that cathepsin B redistribution is dependent upon the presence of a supramaximally stimulating concentration of caerulein along with a plasma factor which is expressed in response to in vivo supramaximal caerulein stimulation. Cathepsin B redistribution is also reported to occur when rat pancreatic fragments are exposed, in vitro, to plasma obtained from opossums with duct obstruction-induced pancreatitis.
Methods
Preparation and incubation ofpancreasfragments. The pancreas from 200-g male Wistar rats was harvested and cut into fragments measuring 1-2 mm3. The fragments were suspended in Hepes-Ringer buffer, pH 7.4, containing 118 mM NaCl, 5 mM KC1, 1 mM MgCl2, 1 .26 mM CaCl2, 10 mM Hepes, 0.01% soyabean trypsin inhibitor, and 1% Ea- gle's basal amino acids. When indicated, this buffer was augmented by addition of caerulein (0.1 M) and/or rat or opossum plasma (80%, vol/vol). Pancreas fragments were incubated at 37°C under an atmosphere of 95% 02-5% CO2 for 4 h before subcellular fractionation. At the conclusion of each incubation, the pH was measured and consistently found to be 7.4±0.1.
Subcellularfractionation. Pancreas fragments were washed twice in pH 7.0 buffer containing 5 mM Mops, 1 mM MgSO4, and 250 mM sucrose. After washing, they were homogenized by two up-and-down strokes of a motorized glass-teflon homogenizer. Unbroken cells and debris were removed by low-speed centrifugation (150 g x 10 min, 4°C). The resulting supernatant was considered to be the entire sample for later calculations and to contain 100% ofall measured components.
Subcellular fractionation was performed using differential centrifugation as described by Tartakoffand Jamieson (1 1) with minor modifica-tions which have been previously reported (6) . Briefly, the supernatant described above was centrifuged (1,000 g X 15 min, 4C) to yield a "zymogen granule" pellet and a supernatant. The latter was harvested and centrifuged (12,000 g X 12 min, 4C) to obtain a "lysosomal" pellet and a supernatant. This supernatant was centrifuged (105,000 g x 60 min, 4C) to obtain a "microsomal" pellet and postmicrosomal supernatant or "soluble" fraction. The various fractions were characterized by measuring markers (DNA, RNA, amylase, cathepsin B, cytochrome oxidase) as previously described (10) .
Preparation of "caerulein-plasma". Male Wistar rats weighing -200 g were anesthetized with pentobarbitol (1.5 mg/rat i.p.) and a PE-10 cannula was placed in the external jugular vein. The animals were allowed to awaken and recover from the anesthetic overnight while the patency of the cannula was maintained by infusion of 150 mM NaCl containing 30 U/ml heparin at a rate of0.21 ml/h. The next day, each animal was infused with a similar solution containing caerulein at a concentration calculated to deliver 5 ,ug/kg per h. After infusion ofthis supramaximally stimulating dose ofcaerulein for 3.5 h, the animals were sacrificed and plasma harvested for later use. All animals infused with this supramaximally stimulating dose of caerulein were observed to have grossly obvious pancreatic edema. For the most part, the plasma harvested from these caerulein-infused rats (termed "caerulein-plasma") was used within 48 h of caerulein infusion. Pilot experiments were performed which indicated that the effects of this plasma on the subcellular distribution of cathepsin B in pancreas fragments reported in this manuscript were not changed by the storage of the plasma, at 4°C, for up to 1 wk.
Preparation of opossum pancreatitis plasma. Randomly trapped, healthy opossums (Didelphis virginiana) ofeither sex weighing 2.4-3.9 kg were fasted overnight and then anesthetized with an intraperitoneal injection of pentobarbital (50 mg/kg). Using sterile technique, a midline upper abdominal incision was made, the cystic duct ligated, and the common bile/pancreatic duct ligated adjacent to the wall of the duodenum. Jaundiced control animals underwent the same procedure, including cystic duct ligation, but the common bile duct was ligated on the liver side of the pancreas (i.e., proximal to its junction with the pancreatic duct). Thus, in the jaundiced control animals, pancreatic juice continued to flow into the duodenum. The abdominal incision was then closed and the animals maintained on food and water ad libitum for 7 d. They were then sacrificed with a lethal dose of pentobarbital, blood harvested from the right ventricle, and the pancreas examined. All of the animals with bile/pancreatic duct ligation had gross morphologic evidence ofpancreatitis including fat and parenchymal necrosis, pancreatic edema, and areas of intrapancreatic hemorrhage. The jaundiced control animals had no gross changes suggestive of pancreatitis. These observations are consistent with those reported by Senninger et al. (12) . Serum amylase values were 1,655+774 and 270±68 U/ml in the pancreatitis andjaundiced control animals, respectively. Pancreatic water content was 78±3 and 70±1% in the pancreatitis and control animals, respectively. Serum samples were prepared immediately and stored frozen (-20°C) until later use.
Deproteination and ultrafiltration ofplasma. Caerulein plasma was deproteinated by either heat or alcohol denaturation. The former was accomplished by addition of boiling water to the plasma sample (25% vol/vol), whereas the latter was achieved by addition of acidified ethanol (40%, vol/vol; pH 4.0). In each case, the resulting protein precipitate was removed by centrifugation and the remaining supernatant was concentrated to the original volume by speed-vac. In the process, the ethanol was removed. Caerulein plasma was ultrafiltered using centiprep-10 and centiprep-30 membranes which have molecular weight cutoffs of 10,000 and 30,000, respectively.
Enzyme assays. Cathepsin B activity was measured fluorimetrically using CBZ-arginyl-arginine-B-napthylamide as the substrate as described by McDonald and Ellis (13) with minor modifications (4). Amylase, DNA, RNA, and cytochrome oxidase were evaluated as described previously (10) .
Material. Analysis of data. The results reported in this paper represent the mean ±SEM obtained from at least three separate experiments (with duplicated incubation in every experiment) for each observation. Error bars in the figures indicate SEM values, whereas the absence of these bars indicate that the SEM values were too small to illustrate. Analysis ofvariance was used to evaluate the significance ofobserved changes. If ANOVA indicated significant differences, then the means were evaluated by a multiple comparison method of Tukey (14) as described by Zar (15) . The differences were considered significant ifthe q value was more than the critical value when a < 0.05.
Results
The subcellular distribution of cathepsin B in rat pancreatic fragments incubated in Hepes-Ringer buffer for 4 h is shown in (Fig. 1) . In contrast, a significant change in the subcellular distribution of cathepsin B was noted when the fragments were incubated with 0.1 uM caerulein combined with 'Preliminary experiments indicated that a maximal rate of amylase secretion from pancreas fragments occurred in the presence of 1 nM caerulein and that higher concentrations caused inhibition of amylase secretion. The dose chosen for use in these in vitro studies, 0.1 M, consistently caused inhibition ofamylase secretion. Incubation ofpancreas fragments with buffer containing higher concentrations of caerulein (I MM) also did not cause in vitro cathepsin B redistribution. plasma that had been harvested from rats previously infused with 5 ,gg/kg per h caerulein for 3.5 h ("caerulein plasma") ( Fig.   1 ). Under those conditions, whereas cathepsin B total activity remained unchanged (not shown), the percent of cathepsin B activity in the zymogen granule-enriched fraction rose from 20.2±1.0 to 34.0±2.5% and declined in the lysosome-enriched fraction from 60.0±1.5 to 49.0±0.5%. These changes are highly significant (P < 0.01). In contrast, the activity ofcathepsin B in the microsomal and in the soluble (cytosolic) fractions was not altered by incubation in caerulein-plasma plus caerulein (data not shown). These findings indicate that in vitro incubation of pancreas fragments in either buffer or normal plasma containing a supramaximally stimulating concentration of caerulein does not cause subcellular redistribution of cathepsin B but that redistribution of cathepsin B from the so-called lysosomal fraction (12,000 g X 10 min pellet) to a more dense fraction normally enriched in zymogen granules (1,000 g x 10 min pellet) occurs when pancreas fragments are incubated with a supramaximally stimulating concentration of caerulein along with plasma taken from rats which had been subjected to in vivo supramaximal caerulein stimulation.
The subsequent studies were undertaken to characterize the plasma factor(s) expressed after in vivo supramaximal caerulein stimulation which was found to permit in vitro subcellular redistribution of cathepsin B. The ability of caerulein-plasma to permit in vitro cathepsin B redistribution was found to be lost when the plasma was deproteinated either by heat or acidethanol denaturation (Table I ). These observations indicate that the plasma factor expressed in response to in vivo caerulein infusion which permits in vitro cathepsin B redistribution is a protein. In vitro redistribution ofcathepsin B did not occur when pancreas fragments were incubated with caeruleinplasma to which the protease inhibitors phenylmethylsulfonyl fluoride (PMSF) and soyabean trypsin inhibitor had been added (Fig. 2) . This finding indicates that in vitro cathepsin B redistribution is dependent upon the presence ofprotease activity. Using the technique of ultrafiltration, the plasma factor was found to pass through 30,000 but not 10,000 mol wt permeable filters (Table II) suggesting that it has a molecular weight of between 10,000 and 30,000 D. Incubation of pancreas fragments in caerulein-plasma was found to stimulate amylase secretion (data not shown), an observation which suggested that caerulein-plasma contains significant concentrations of a pancreatic secretagogue most (Table I ). This observation, combined with the finding that in vitro redistribution of cathepsin B did not occur when fragments were incubated in buffer or normal plasma containing a supramaximally stimulating concentration of caerulein ( Fig.  1) , indicates that in vitro redistribution of cathepsin B results from the combined effects of cholecystokinin receptor occupancy by an agonist and exposure to the plasma factors expressed in response to in vivo supramaximal stimulation.
The time-and concentration-dependent effects of the in vitro cathepsin B redistribution phenomenon are shown in Figs. 3 and 4 . Incubation of fragments with caerulein-plasma plus a supramaximally stimulating concentration of caerulein for < 2 h did not cause significant cathepsin B redistribution. The redistribution phenomenon was clearly evident after 2 h in vitro incubation and appeared to be complete after 4 h incubation. The effect of longer in vitro incubation periods could not be evaluated because of poor tissue viability after incubation for longer than 4 h.
Dilution of caerulein-plasma was noted to cause progressive reductions in the magnitude of in vitro cathepsin B redistribution. The use of concentrated caerulein-plasma (three times concentrated using Amicon filters) did not result in greater subcellular cathepsin B redistribution than that noted with unconcentrated caerulein-plasma suggesting that maximal in vitro subcellular redistribution of cathepsin B was induced by exposure to an 80% (vol/vol) solution of caeruleinplasma plus caerulein.
The above finding suggested that a plasma protease was elaborated during caerulein-induced pancreatitis which could cause in vitro cathepsin B redistribution. To determine whether a similar phenomenon might be associated with other models ofexperimental pancreatitis, we evaluated the effects of plasma obtained from opossums after 7 d of either bile duct ligation ("jaundiced controls") or pancreatic plus bile duct ligation. In accord with the report of Senninger et al. (12) , pancreatic-bile duct ligation was found to cause gross and microscopic changes typical of acute necrotizing pancreatitis. As shown in Fig. 5 , subcellular redistribution of cathepsin B was observed when rat pancreatic fragments were incubated, in vitro, with caerulein combined with plasma obtained from opossums after pancreatic plus bile duct ligation but not with plasma obtained from the jaundiced control animals that had only bile duct ligation and, as a result, did not have pancreatitis. As had been noted in experiments using rat plasma, the in vitro redistribution ofcathepsin B was dependent upon the simultaneous presence of the plasma factor and caerulein stimulation. When the CCK antagonist L-364,7 18 was added to opossum plasma obtained from jaundiced control animals, 28±1% of cathepsin B was recovered in the zymogen granule fraction and 50±3% in the lysosome fraction (n = 3). When the CCK antagonist was added to opossum plasma obtained from animals with pancreatic duct ligation-induced pancreatitis, 27±2% of cathepsin B was recovered in the zymogen granule fraction, whereas 52±2% was recovered in the lysosome fraction (n = 3). There was, therefore, no significant difference noted when data from pancreatitis and jaundiced control samples plus L-364,7 18
were compared (P > 0.05). Digestive enzyme zymogens and lysosomal hydrolases such as cathepsin B are synthesized on the rough endoplasmic reticulum and cotransported to the Golgi where the two types of enzymes are segregated from each other (17, 18) . In previously reported studies, we have shown that in vivo subcellular redistribution ofcathepsin B results from a derangement ofthe normal sorting events as well as from crinophagy (2) . The observations reported in this manuscript suggest that a supramaximally stimulating concentration of caerulein when present in vitro along with plasma factor(s) expressed in response to in vivo supramaximal stimulation can also derange the normal sorting events. It is likely that, in this case, caerulein as well as the plasma factor(s) affect intracellular sorting by acting at surface membrane sites but the mechanisms by which intracellular trafficking and sorting are altered remain unknown. It is clear, however, that inhibition of secretion is not, by itself, sufficient to cause redistribution of cathepsin B because digestive enzyme secretion is inhibited by a supramaximally stimulating concentration of caerulein even in the absence of the plasma factor(s). Similarly, interaction of an agonist such as caerulein with low-affinity receptors, a phenomenon recently noted to play a role in secretagogue-induced pancreatitis (19) , cannot by itself be the cause of redistribution because low-affinity receptor occupancy by caerulein occurs even in the absence of the plasma factor(s).
Discussion
Studies aimed at elucidating the events which are critical to intracellular sorting of newly synthesized proteins have been hampered by the relatively few maneuvers which can perturb the sorting process. For the most part, experimental modulation of that phenomenon has involved the use of agents which interfere with transport of lysosomal enzymes to lysosomes by preventing acidification of the lysosomal compartment (20, 21) . When redistribution of lysosomal hydrolases has been induced by in vivo exposure to a supramaximally stimulating dose of caerulein, lysosomal and digestive enzymes have been found to be colocalized in cytoplasmic vacuoles which have an acidic pH (22). Based on that observation, it would appear unlikely that the in vitro redistribution phenomenon is caused by a failure of lysosomal acidification although studies directly evaluating lysosomal pH after in vitro redistribution will be needed to settle this issue. Ifdefective lysosomal acidification is not found to underlie in vitro redistribution, the system described in this report may represent a useful alternative method of perturbing intracellular trafficking and, as such, may prove useful for studies probing the events which are critical to that process.
The redistribution phenomenon elicited by in vitro exposure to caerulein plasma along with a supramaximally stimulating concentration of caerulein differs in at least two ways from that which is elicited by in vivo exposure to a supramaximally stimulating dose ofcaerulein. First, the magnitude ofcathepsin B redistribution is significantly less when the phenomenon is elicited in vitro than when it is induced in vivo. For example, after in vivo redistribution 50-60% of cathepsin B activity can be recovered in the zymogen granule-enriched fraction whereas only 25-35% of cathepsin B activity is recovered in that subcellular fraction after in vitro redistribution. The second difference involves the relative paucity of morphological changes after in vitro redistribution. We (2) (3) (4) (5) and others (9, 22) hydrolases become colocalized within those vacuoles (3). In contrast, although incubation of pancreas fragments for 4 h in buffer without caerulein or the plasma factor(s) results in a modest degree ofcytoplasmic vacuolization, no increase in vacuolization or colocalization of digestive enzymes with lysosomal hydrolases is noted when a supramaximally stimulating concentration of caerulein and caerulein plasma are present (Meldolesi, J., A. Villa, and M. Lerch, unpublished observation). It is likely that these two differences between the in vivo and in vitro redistribution phenomena are interrelated, i.e., that morphological changes elude detection because the magnitude of redistribution is low. Furthermore, the relatively small magnitude of in vitro redistribution suggests that factors in addition to those in the plasma and a supramaximally stimulating concentration of caerulein may play important roles in determining the magnitude of cathepsin B redistribution.
Subcellular redistribution oflysosomal hydrolases has been noted in three distinctly different experimental models of pancreatitis. In addition to the model involving supramaximal secretagogue stimulation (4), lysosomal enzyme redistribution has been observed after short-term pancreatic duct obstruction (6) and after ingestion of a choline-deficient ethionine-supplemented diet (5). These observations suggested that those models might also involve elaboration of a plasma factor which could induce in vitro cathepsin B redistribution. Studies evaluating this issue in the diet-induced model of pancreatitis are impractical because the ethionine-containing diet only induces hemorrhagic pancreatic necrosis in young (10-15 g) mice (23) , and harvesting of sufficient quantities of plasma from these animals would be difficult. Senninger has noted that ligation of the opossum pancreatic and bile duct induces necrotizing pancreatitis. In this report, we note that in vitro subcellular cathepsin B redistribution also occurs when rat pancreatic fragments are incubated with caerulein plus plasma obtained from opossums with pancreatic plus bile duct ligation-induced pancreatitis. On the other hand, in vitro redistribution does not occur when rat pancreatic fragments are incubated with caerulein combined with either normal opossum plasma or plasma obtained from jaundiced control opossums that had undergone only bile duct ligation and did not have pancreatitis. In vitro redistribution was noted only when opossum pancreatitis plasma was combined with caerulein and it was not seen when the CCK antagonist L-364,718 was added to plasma taken from animals with pancreatic duct ligation-induced pancreatitis. These findings indicate that, as with caerulein-induced pancreatitis in rats, the plasma factor which is elaborated can induce in vitro cathepsin B redistribution only when its presence is combined with caerulein stimulation in vitro. Furthermore, these observations suggest that elaboration of a plasma factor capable of inducing in vitro cathepsin B redistribution may be a general feature of other forms of acute pancreatitis as well.
